Most major commercial insurers now cover FDA-approved obesity medications (Wegovy, Saxenda, Zepbound) with prior authorization
In this study, we found a significant effect on appetite suppression and body weight loss when combining the two peptides over a period of nine weeks, an effect superior to either monotherapy alone
Adapted from: AACE/ACE Obesity CPG, Endocr Pract
If youre exploring care in the Stamford, Greenwich, or Norwalk area, start with our GLP1 Weight Loss Program
2 mL equals 200 units on a U-100 insulin syringe, or two full 1 mL syringes drawn and added to the vial
A: If benefits occur, they are usually gradual over weeks